45J-14617-26582
1 vaccination
0 coded responses
11 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 554 / MN
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Registered in v-safe
-
2021-04-09
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-09
-
2021-04-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-10
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activitiesno matching call case
- 2021-04-11
- 2021-04-12
- 2021-04-14
- 2021-04-25
- 2021-05-07
- 2021-05-16
- 2021-07-11
- 2021-10-10
- 2022-04-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|
1 report(s) with no call case — see the timeline.
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.